Yersinia pasteurella fransicella

3,270 views 33 slides Dec 04, 2015
Slide 1
Slide 1 of 33
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33

About This Presentation

Yersinia pasteurella fransicella for undergraduates


Slide Content

Yersinia, pasteurella&
francisella

PASTEURELLA
YERSINIA
Y.PESTIS
Y.PSEUDOTUBERC
ULOSIS
Y.
ENTEROCOLITICA
PASTEURELLA
P.MULTOCIDA
FRANCISELLA
F.TULARENSIS
GRAM NEGATIVE ,
SHORT BACILLI,
RODENT PATHOGENS
CULTURE,
BIOCHEMICALS

YERSINIA PESTIS
PLAGUE BACILLI
DISCOVERED BY YERSIN &
KITASATO IN 1894

MORPHOLOGY
•Gram Negative
•Short bacilli with rounded ends
•Appears in singles, short chains or short groups
•Non notile, non sporing
•Non acid fast
•Bipolar staining ( Safety pin appearance)
•Pleomorphism
•Pleomorphismenhanced in media containing
3%NaCl

•When smears are stained with giemsastain or
methylene blue stain the two ends stain
deeply leaving a clear central area.

CULTURE
•Aerobic & facultative anerobic
•pH –5-9.6, optimum pH 7.2
•Temperature –2-45°
•Best growth at 27 degrees
•Envelope develops best at 35 Degrees

Colony morphology
•Nutrient agar –small delicate transparent disc
which becomes opaque on prolonged incubation.
•Blood agar –Dark brown due to absorption of
heminpigment
•Mac Conkeyagar –colorless colonies
•Growth in broth –Flocculent growth at bottom
and side of tube
•Ghee broth –Stalactite growth (Growth hangs
down from the broth surface)

Biochemicals
•Catalase –Positive
•Oxidase-Negative
•Indole–Negative
•Methyl red –positive
•VP –Negative
•Citrate –negative
•Urease–positive
•Sugars –Glucose, Maltose and Mannitol
fermented . No Gas production

Resistance
•Easily desroyedby heat, sunlight, drying and
chemical disinfectants
•Killed by 55°C
•0.5% phenol
•Viable in cold moist environments
•All strains lysedby a antiplaguebacteriophage
at 22°C

Virulence factors
•Protein envelope (F-I)
–Plasmid coded
–Present only in virulent strains
–Heat labile
–Best developed at 37°C
–Inhibits phagocytosis
–Antibody to this antigen is protective in mice
•V and W antigens
–Always produced together
–Plasmid mediated
–Inhibits phagocytosis & intracellular killing of bacilli.

Virulence factors
•Bacteriocin
–PesticinI
–Inhibits Y.pseudotuberculosis, Y.enterocoliticaand E.coli
•Coagulase
•Fibrinolysin
•Plague Toxins (Murinetoxins*)
–Endotoxin
•LPS
–Protein
•Has both properties of exotoxinand endotoxin
•Thermolabile
•Can be toxoided
•Toxicity predominantly in Rats and Mice*
•Local injection produces edema, necrosis
•Affects peripheral vascular system and Liver

Plague
Pandemics and epidemics
Black Death –Cutaneous hemorrhage and necrosis.
41 epidemics in BC era
109 epidemics in AD
Last epidemic in 1894
Reached Bombay in 1896
Spread all over country with 10million deaths till 1918
Now endemic foci persists

•Human infection
–Bubonic
–Pneumonic
–Septicemic
•BUBONIC PLAGUE
•Incubation period 2-5days
•Draining lymph nodes become infected
•Most common bite is in legs enlargement of inguinal lymph nodes (BUBONIC –
Bubon–Groin)
•Glands enlarge and suppurate
•Septicemia
•Hemorrhages , DIC Gangrene of Skin, Fingers and penis
•Case fatality –30-90%
Plague
PESTIS MINOR

PNEUMONIC PLAGUE
•Seen during epidemics of bubonic
plague
•Epidemic of pneumonic plague rare
•Spread by droplet infection
•Hemorrhagic pneumonia.
•Cyanosis.
•Bloody mucoid sputum that is coughed
out is highly infectious
•Mostly fatal
SepticemicPLAGUE
•Terminalevent of bubonic / pneumonic plague
•May occur as primary infectionrarely
•Meningeal involvement may be present
•asym,ptomaticorophryngealcarrier state has been observed
•No human carriers

Infected Rat
Bitten by
Rat flea
Bacilli
multiply in
stomach
Blocks proventiculus
(blocked flea)
Extensive
multiplication
Extrinsic incubation period
Tries to bite the
next rodent
Regurgitates the
bacilli along with
bite
Infected
second
rat
Death of rats
( Rat fall)
Flea leaves the
carcass
Rat
Human
Bubonic plague
Contamination of bite wound
with feces of flea

Vectors
Xenopsylla cheopis
•Xenopsylla astia
•Ceratophyllus fasciatus
•Epidemics occur in cool , humid seasons favors
multiplication of fleas.
•High flea index

Epidemiology
•Epizootic in Rattusnorvegicus( sewer rat)
•As the population came down the infection spread to domestic rats.
•Urban cycle / Domestic cycle
•Wild / Sylvaticcycle
•Infected fleas live for an year.
•Y.pestiscan live & multiply in soil ( abandoned burrows) infects
new rodents re-emergence of disease after a long period.

Lab diagnosis
•In Rats
–May have ectoparasites
–Kerosene/ 3%lysol can be used to eliminate ectoparasites
–Buboes in cervical region –Hard and moves under the skin
–c/s –Congestion, Hemorrhagic points or grey necrosis
–Smear –bipolar staining, pleomorphism
–Fluorescent antibody technique –impression films

F-ab stain

•Liver –motledwith red , yellow or grey stippling
•Spleen –enlarged, granular or nodular
•Pleural effusion –Clear, abundant or straw coloured. Rarely blood
stained
•Culture –from buboes, spleen, heart blood and bone marrow ( in
decomposed carcasses)
•In case of putrefied carcasses –putrifiedtissue may be rubbed on
shaven abdomen of guinea pig F1 antigen (immunofluorescence)
Lab diagnosis

Lab diagnosis
•In human
–Bubonic plague
•Microscopy
•Culture: blood cultures often positive
•Animal inoculation
–Pneumonic plague
•Bacilli in Sputum microscopy
•Culture
•Animal inoculation
–Serological diagnosis
•Antibidiesto F-1 antigen (>128)
•IgM/IgG ELISA
•PCR

Prophylaxis
•Control of fleas and rodents
•Vaccines
–Killed –prepared by Haffkineinstiute,Mumbai
•Given s/c , 2 doses, 3 months interval followed by 3
rd
dose 6
months later
•No protection against pneumonic plague
•Infection gives better immunity compared to vaccination
•At risk patients –cotrimoxazoleor tetracycline for 5days
•No use in outbreaks/ mass vaccination
–Live attenuated –Otten’sTjiwidejstrain –Indonesia
Girard’s strain –malagasy
•Not in use due to severe reactions

Treatment
•Streptomycin
•Doxycycline
•Chloramphenicol

Yersiniosis
Zoonoticinfections by Y.pseudotuberculosis & Y.enterocolitica
•Y.pseudotuberculosis
•Resembles Y.Pestis
•Poor growth on Mac Conkeyagar
•Motile at 22°C but non motile at 37°C
•Urease–Positive
•Not lysedby antiplaguebacteriophage
•6 serogroupsbased on somatic and flagellarantigens
•Infected guinea pigs multiple nodules seen in Liver, Spleen and Lungs resembling
tuberculosis Pseudotuberculosis.
•Human infection –Fatal typhoid like illness with
–Hepatospeenomegalyand purpura
–Mesentriclymphadenitis
–Erythema nodosum
–Gastroenteritis

Yersiniosis
Zoonoticinfections by Y.pseudotuberculosis & Y.enterocolitica
•Y.enterocolitica
•Biochemical differences
•More than 60 o serotypes
•Most common human infections –03, 08 & 09
•Self limited gastroenteritis/ enterocolitis
•Mesentricadenitis / inflammatory terminal ileitis
•Systemic disease –Bacteremia, meningitis , arthralgia or erythema nodosum
•People with HLA –B27 are more prone to reactive arthritis

Pasteurellamultocida
•Hemorrhagic septicemia in animals and birds
–Gram negative bacillus
–Non motile
–Oxidasepositive
–Indolepositive
–Do not grow on Mac Conkeyagar
•May be seen as commensal in animals and humans
•Human infection rare –follows bite/trauma
–Local suppuration
–Meningitis
–Respiratory tract infection
–Appendicitis
•Treatment
•Penicillin, Tetracycline & Streptomycin

Francisellatularensis
•Tularemia
•Transmitted by ticks / ingestion of contaminated meat or
water / inhalation of infective aerosols
•Minute GNB, Non motile, Capsulated.
•Multiply by filament formation and budding
•Intracellular parasite –Liver and spleen cells
•FRANCI’S BLOOD DEXTROSE CYSTINE AGAR -
minute colonies after 3-5days

Tularemia
•Local ulceration with lymphadenitis
•Typhoid like fever with glandular enlargement
•Influenza like respiratory infection
•Water borne infection
•Diagnosis by culture or inoculation in guinea pigs/mice
•Agglutinating antibodies
•Attenuated vaccine –administered by scarification